You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This book addresses the basic and advanced knowledge on psychiatric disorders for non-clinicians. The volume compiles in-depth information on the psychopharmacogenetic, representing an important area of research that is based on various specialties including clinical psychiatry, pharmacology, neurobiology and genetics. The book also addresses questions related to the field of psychiatric disorders that are not usually addressed in one work. The questions considered include: What is schizophrenia? What are the risk factors? What are the core symptoms? How is it treated? What are the efficacy and side effects of the available treatments?
The 2nd edition of the Dictionary of Disaster Medicine and Humanitarian Relief is an essential and practical reference for all those who work in humanitarian relief. This new, expanded edition presents more than 3000 definitions and acronyms covering the entire multidisciplinary scope of disaster medicine and humanitarian relief, as well as new fields such as climate change and bioterrorism. As natural disasters, humanitarian emergencies, and infectious disease epidemics increase in frequency and seriousness, this book is an important reference to assist international relief workers communicate with each other and with the media. The author has served as both the director of Emergency Humanitarian Operations of the World Health Organization, as well as the WHO’s chief of scientific terminology. As the Director-General Emeritus of the World Health Organization says in the Foreword, “This new expanded edition comes as a timely essential aid against the growing threats of inhuman violence and destructive disasters.”
This interdisciplinary reference identifies and elucidates the most influential developments in chemical genomics for improved research and advancement in a diverse array of fields ranging from proteomics, bioinformatics, and microfluidics to drug discovery and toxicology. The book tracks the emergence of a large variety of novel techniques such as the small-molecule drugability of new targets, the generation and synthesis of small-molecule libraries, and the determination of targets and mechanisms by genomic profiling and guides readers in the selection of the most appropriate technology for their specific dilemma by highlighting procedures utilized in other scientific disciplines.
Recent major earthquakes, tsunamis, hurricanes, floods and other natural phenomena have resulted in huge losses in terms of human life and property destruction. A new range of human-made disasters have afflicted humanity in modern times; terrorist activities have been added to more classical disasters such as those due to the failure of industrial installations. It is important to understand the nature of these global risks to be able to develop strategies to prepare for these events and plan effective responses in terms of disaster management and the associated human health impacts. The selected papers contained in this book have been written by academics and professionals and represent some of the latest developments in the field.
Cardiovascular and metabolic diseases remain the number one cause of death in developed countries and their prevalence is increasing rapidly in developing nations. This book brings together the recent information on these disorders and the links that exist between them in order to provide a complete picture of drug discovery for these conditions. The main three sections comprehensively discuss obesity, hypertension and cardiovascular disease, and diabetes in turn, following an introduction to the molecular links between them. The final chapter provides perspectives on future directions of the field. Chapters are contributed by leaders in the field from academia and industry and cover biomark...
None
None
Serotonin (5-hydroxytryptamine, often cited as 5-HT) is one of the major excitatory neurotransmitter, and the serotonergic system is one of the best studied and understood transmitter systems. It is crucially involved in the organization of virtually all behaviours and in the regulation of emotion and mood. Alterations in the serotonergic system, induced by e.g. learning or pathological processes, underlie behavioural plasticity and changes in mood, which can finally results in abnormal behaviour and psychiatric conditions. Not surprisingly, the serotonergic system and its functional components appear to be targets for a multitude of pharmacological treatments - examples of very successful d...
Given the success of the previous edition of this Research Topic, we are pleased to announce the release of its second volume. Age-related changes can concurrently affect cognitive, motor, and sensory functioning and their interactions. For instance, age-related unisensory impairments have been linked to slower gait, functional mobility decline, increased risks of falls and reduced quality of life. Additionally, balance impairments have been associated with inefficient interactions between musculoskeletal and sensory systems which are often compromised in aging. Lastly, inefficient multisensory integration processes have been linked to increased falls, worse balance, slower gait, and increased cognitive impairments. Consequently, the successful interaction among sensory, motor and cognitive systems are an integral aspect for everyday life activities, which commonly deteriorate with age.
Schizophrenia remains an important challenge to psychiatry, with its causes and underlying brain mechanisms yet to be fully revealed. Currently available treatments are neither universally effective nor without unwanted effects. These aspects, together with the high prevalence of schizophrenia, its often debilitating nature, and the associated family and social burden, make this mental disorder one of the most complex public health issues of our times. The purpose of the Advances in Schizophrenia Research series is to provide comprehensive periodic reviews of the wide range of research studies carried out around the world, with the dual purpose of solving the schizophrenia puzzle, and providing clues to new forms of treatment and prevention for this disorder. A special feature of the series is its broad scope, virtually encompassing all fields of schizophrenia research: epidemiology and risk factors; psychopathology; diagnostic boundaries; cognition; outcome and prognosis; pathophysiology; genetics; pharmacological and psychological forms of treatment and rehabilitation; community care; and stigmatization.